永泰地产(00369.HK)夥董建华胞弟及吕耀东等设合营购伦敦写字楼物业
永泰地产(00369.HK)公布,与前东方海外(00316.HK)主席、政协副主席董建华胞弟董建成、银娱(00027.HK)副主席吕耀东以及罗嘉瑞旗下冠君产业信托(02778.HK)成立合营企业,以2.55亿英镑(约27.96亿港元)收购位於66 Shoe Lane, London EC4A 3BQ的伦敦写字楼物业,前称Athene Place。
该合资公司分别由董建成持有31%、冠君持有27%、永泰及吕耀东各持有21%。公司将斥5,420万元英镑向合营出资,以内部资源及或借款拨付。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.